LEADER 03292nam  22005535  450 
001 9910253860803321
005 20200701020601.0
010   $a4-431-55966-3
024 7 $a10.1007/978-4-431-55966-5
035   $a(CKB)3710000000627612
035   $a(EBL)4461652
035   $a(SSID)ssj0001654062
035   $a(PQKBManifestationID)16432971
035   $a(PQKBTitleCode)TC0001654062
035   $a(PQKBWorkID)14982911
035   $a(PQKB)10752292
035   $a(DE-He213)978-4-431-55966-5
035   $a(MiAaPQ)EBC4461652
035   $a(PPN)192770748
035   $a(EXLCZ)993710000000627612
100   $a20160330d2016      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aHuman iPS Cells in Disease Modelling /$fedited by Keiichi Fukuda
205   $a1st ed. 2016.
210  1$aTokyo :$cSpringer Japan :$cImprint: Springer,$d2016.
215   $a1 online resource (102 p.)
300   $aDescription based upon print version of record.
311   $a4-431-55964-7 
320   $aIncludes bibliographical references at the end of each chapters.
327   $aChapter 1 Recent Improvements and Emerging Issues in iPSC Generation for the Modeling of Disease -- Chapter 2 Cardiomyopathy -- Chapter 3 Modelling Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy with Patient-specific iPSCs -- Chapter 4 Cardiac Arrhythmia Modelling Using iPS Cells -- Chapter 5 iPSC Disease Modeling of Laminopathies -- Chapter 6 Hematological Disorders -- Chapter 7 Inherited Metabolic Disorders of the Liver. .
330   $aHuman iPS cells have a great potential to be cell sources for regenerative medicine because of the promise of infinite self-renewal and the capability to differentiate into multiple cell types. This book focuses on another great potential of human iPS cells, which is the establishment of human disease models using patient-specific iPS cells. Human iPS cells can be easily obtained from a patient?s somatic cells and provide the entire information on the patient?s genome. Accordingly, we can generate disease models for inheritable diseases in cell culture dishes using iPS cells. This is a quite new technique but holds tremendous potential for our increased understanding of pathogenesis, and will then be the basis for novel drug development industries. All the authors are leading researchers in this field and they have reported many kinds of patient-derived iPS cells. In this book, they introduce the aspects that could be recapitulated in terms of disease modelling as well as further innovative findings such as novel pathogenetic insights and novel therapies. .
606   $aStem cells
606   $aCell culture
606   $aStem Cells$3https://scigraph.springernature.com/ontologies/product-market-codes/L16010
606   $aCell Culture$3https://scigraph.springernature.com/ontologies/product-market-codes/L16020
615  0$aStem cells.
615  0$aCell culture.
615 14$aStem Cells.
615 24$aCell Culture.
676   $a570
702   $aFukuda$b Keiichi$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910253860803321
996   $aHuman iPS Cells in Disease Modelling$92526691
997   $aUNINA